Loading...
NYSE: BAX
Baxter International Inc.
Healthcare · Medical - Instruments & Supplies
●S&P 500 since 1972
Market Cap
$8.52B
52w High
$34.52
52w Low
$16.55
P/E
-8.90
Volume
3.15M
Outstanding Shares
514.49M
Company profile
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.
CEOAndrew Hider
SectorHealthcare
IndustryMedical - Instruments & Supplies
Employees38,000
IPO dateOct 27, 1981
Valuation
Forward P/E—
EV/EBITDA23.29
Enterprise value$17.84B
Stock splits
Jul 1, 20151841:1000
May 31, 20012:1
Dec 1, 1992100000:90823
Nov 18, 19832:1
Nov 9, 19812:1
Profitability & growth
Revenue growth8.03%
Gross margin30.05%▼19.77%vs FY2024
Operating margin-2.74%▼2181.04%vs FY2024
ROE-15.61%▼67.55%vs FY2024
Analyst consensus
RatingHold
Target price$19.75▲19.23%
15
Buy
20
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$0.59
$0.60
Q3FY25
ActualEst.
$0.69
$0.60
Q4FY25
ActualEst.
$0.44
$0.54
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$2.81B
$2.88B
Q3FY25
ActualEst.
$2.84B
$2.82B
Q4FY25
ActualEst.
$2.97B
$2.61B
Q1FY26
Next Est.
—